Change - Announcement of Appointment::Appointment of Lead Independent Director - Mr. Tan Chade Phang
Issuer & Securities
Issuer/ Manager
AOXIN Q & M DENTAL GRP LIMITED
Securities
AOXIN Q & M DENTAL GRP LIMITED - SG1DF9000000 - 1D4
Stapled Security
No
Announcement Details
Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
28-Apr-2026 19:10:03
Status
New
Announcement Sub Title
Appointment of Lead Independent Director - Mr. Tan Chade Phang
Announcement Reference
SG260428OTHRWH1P
Submitted By (Co./ Ind. Name)
Mr Chua Ser Miang
Designation
Non-Executive and Non-Independent Chairman
Description (Please provide a detailed description of the event in the box below)
Appointment of Mr. Tan Chade Phang as Lead Independent Director of Aoxin Q & M Dental Group Limited (the "Company").
This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor").
This announcement has not been examined or approved by Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Ms. Foo Jien Jieng, 16 Collyer Quay, #10-00 Collyer Quay Centre. Singapore 049318, sponsorship@ppcf.com.sg.
Additional Details
Date of appointment
28/04/2026
Name of person
Tan Chade Phang
Age
49
Country of principal residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The appointment of Mr. Tan Chade Phang ("Mr. Tan") as Lead Independent Director of the Company was recommended by the Nominating Committee ("NC") and approved by the Board of Directors of the Company (the "Board"). In assessing the suitability of Mr. Tan's appointment as Lead Independent Director of the Company, the NC took into consideration Mr. Tan's credentials, qualifications and work experience. The NC and the Board are of the view that Mr. Tan's appointment will enhance the Board's core competencies and skills sets, taking into account the current Board's balance and mix of skills, knowledge, experience and other aspects of diversity.
Following his appointment as an Lead Independent Director of the Company, Mr. Tan will also be appointed as the Chairman of Audit Committee ("AC") as well as a Member of Nominating Committee ("NC") and Remuneration Committee ("RC").
The Board considers Mr. Tan to be independent for the purpose of Rule 704(7) of the Singapore Exchange Securities Trading Limited Listing Manual Section B: Rules of Catalist.
Whether appointment is executive, and if so, the area of responsibility
Non-Executive
Job title (e.g. Lead ID, AC Chairman, AC Member etc.)
Lead Independent Director, Chairman of AC, Member of the RC and NC.
Professional qualifications
Master of Finance - RMIT University
Bachelor of Business in Accountancy - RMIT University
Working experience and occupation(s) during the past 10 years
CEO - SIAS Research/Voyage Research (Aug 2009 - Sept 2023)
Shareholding interest in the listed issuer and its subsidiaries
No
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Conflict of interest (including any competing business)
No
Undertaking (in the format set out in Appendix 7.7 or Appendix 7H) under Mainboard Rule 720(1) or Catalist Rule 720(1) has been submitted to the listed issuer
No
Other Principal Commitments* Including Directorships#
* "Principal Commitments" has the same meaning as defined in the Code of Corporate Governance.
# These fields are not applicable for announcements of appointments pursuant to Mainboard Rule 704(9) or Catalist Rule 704(8).
Past (for the last 5 years)
SMI Vantage
Luminor Financial Holdings
Revez Corporation Ltd
Camsing Healthcare Ltd
TIH Limited
TBK and Sons Holdings Ltd (HKSE)
Transcorp Holdings Limited
Dapai Intl Hldg Co. Ltd.
Holdings
SIAS Research
Voyage Research
(Previously known as SIAS Research)
OUE Healthcare Limited
Present
Y Ventures Group Limited
Tritech Group Limited
Lancar Corporate Services Pte Ltd
Small and Middle Capitalization Companies Association
Information Required
Disclose the following matters concerning an appointment of director, chief executive officer, chief financial officer, chief operating officer, general manager or other officer of equivalent rank. If the answer to any question is "yes", full details must be given.
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of:-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
Yes
If yes, please provide full details.
Appointed as Independent Director of Dapai Intl Hldg Co. Ltd. in March 2016 and was subsequently appointed as Audit Committee Chairman to oversee the Agreed Upon Procedure (conducted by BDO) and special audit (conducted by KordaMentha) in consultation with the SGX-ST on matters which arose prior to Mr. Tan's appointment as Independent Director of Dapai Intl Hldg Co. Ltd.. The findings of the special audit was released on SGXNet on 7 July 2017.
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere,
in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Disclosure applicable to the appointment of director only.
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If yes, please provide details of prior experience.
Lead Independent and Non-Executive Director, OUE Healthcare Limited
Independent and Non-Executive Director, Y Ventures Group Limited
Independent and Non-Executive Director, Tritech Group Limited
Related Announcements
Related Announcements